ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,685, issued on Aug. 25, was assigned to Inderes LTD (Limassol, Cyprus).

"Drug combination and its use in the treatment of cancer" was invented by Christos Panotopoulos (Limassol, Cyprus).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses a pharmaceutical product comprising L-2,4-diaminobutyric acid (DAB) and prazosin for use in the treatment of cancer by administration to the tumor. The invention also discloses the use of the said at least two active agents in the manufacture of a medicament and methods for the treatment of a cancer comprising intratumoral administration of the pharmaceutical formulation using a novel way ...